American Association for Cancer Research

SHERPA: Unknown

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Goldfarb
    Goldfarb
  4. Dang
    Dang
  5. D'Andrea-Carlino
    D'Andrea-Carlino
  6. Modi
    Modi
  7. Lake
    Lake
  8. Chandarlapaty
    Chandarlapaty
  9. Fornier
    Fornier
  10. Seidman
    Seidman

Groups

  1. Department of Medicine (34)
  2. Solid Tumor Oncology Division (34)
  3. Breast Medicine Service (33)
  4. Survivorship Research (30)
  5. Epidemiology and Biostatistics (28)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)
  7. Population Sciences Research Program (21)
  8. Biostatistics Service (19)
  9. Health Outcomes Research Group (15)
  10. GSK Faculty (13)
Search Within
  1. "Maura Dickler"
Formats
  1. Meeting Abstract (41)
  2. Journal Article (14)
Groups
  1. Department of Medicine (34)
  2. Solid Tumor Oncology Division (34)
  3. Breast Medicine Service (33)
  4. Survivorship Research (30)
  5. Epidemiology and Biostatistics (28)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)

More Groups

People
  1. Maura Dickler (55)
  2. Clifford Hudis (27)
  3. Larry Norton (20)
  4. Shari Goldfarb (15)
  5. Chau Dang (14)
  6. Sujata Patil (14)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (5)
  5. 2017 (6)
  6. 2016 (3)

More Years

Publications
  1. Cancer Research (41)
  2. Clinical Cancer Research (14)

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor–positive breast cancer
    Journal Article

    Chandarlapaty, S.; Dickler, M. N.; Perez Fidalgo, J. A.; Villanueva-Vázquez, R.; Giltnane, J.; Gates, M.; Chang, C. W.; Cheeti, S.; Fredrickson, J.; Wang, X.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Impact of BRCA mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of taselisib (GDC-0032) in combination with fulvestrant in patients with HER2-negative, hormone receptor-positive advanced breast cancer
    Journal Article

    Dickler, M. N.; Saura, C.; Richards, D. A.; Krop, I. E.; Cervantes, A.; Bedard, P. L.; Patel, M. R.; Pusztai, L.; Oliveira, M.; Cardenas, A. K.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Expanded genomic profiling of circulating tumor cells in metastatic breast cancer patients to assess biomarker status and biology over time (CALGB 40502 and CALGB 40503, Alliance)
    Journal Article

    Magbanua, M. J. M.; Rugo, H. S.; Wolf, D. M.; Hauranieh, L.; Roy, R.; Pendyala, P.; Sosa, E. V.; Scott, J. H.; Lee, J. S.; Pitcher, B.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of abemaciclib in patients with liver metastases in the MONARCH 1, 2, and 3 studies
    Meeting Abstract

    Di Leo, A.; Dickler, M.; Sledge, G. W.; Toi, M.; Forrester, T.; Nanda, S.; Koustenis, A.; Bourayou, N.; Johnston, S.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC)
    Meeting Abstract

    Dickler, M. N.; Villanueva, R.; Fidalgo, J. A. P.; Mayer, I. A.; Boni, V.; Winer, E. P.; Hamilton, E. P.; Bellet, M.; Urruticoechea, A.; Gonzalez-Martin, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Improvement in sexual function over time in premenopausal women with breast cancer
    Meeting Abstract

    Goldfarb, S. B.; Kamer, S.; Baser, R.; Quistorff, J.; Gemignani, M. L.; Dickler, M.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • MONARCH 1, a phase II study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR(+)/HER2(-) metastatic breast cancer
    Journal Article

    Dickler, M. N.; Tolaney, S. M.; Rugo, H. S.; Cortés, J.; Diéras, V.; Patt, D.; Wildiers, H.; Hudis, C. A.; O'Shaughnessy, J.; Zamora, E.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • (18)F-fluoroestradiol PET/CT measurement of estrogen receptor suppression during a phase I trial of the novel estrogen receptor-targeted therapeutic GDC-0810: Using an imaging biomarker to guide drug dosage in subsequent trials
    Journal Article

    Wang, Y.; Ayres, K. L.; Goldman, D. A.; Dickler, M. N.; Bardia, A.; Mayer, I. A.; Winer, E.; Fredrickson, J.; Arteaga, C. L.; Baselga, J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: